Diex Research announces the official opening of its Quebec City site since its relocation on September 12, 2022, which is now located at Place de la Cité. Diex Research is a leader in the clinical research industry and is committed to providing superior services to its clients while maintaining the highest standards for safety and ethics.
Read MoreQuebec City, 14-07-2021—DIEX Research, a world-class Quebec-based company that conducts high-quality clinical research, is currently involved in the development of an experimental treatment for “fatty liver disease,” or non-alcoholic fatty liver disease, which affects as many as one in five Canadians, including a growing number of children.
Read MoreDIEX Recherche is proud to announce the opening of its fourth research center in Quebec. CEO Suzie Talbot made the announcement at DIEX Recherche in Sherbrooke. She insists that it is important to have good news to share these days. The opening of a new center will provide the local population of this beautiful region with innovative clinical trials.
Read MoreImmune Biosolutions, Diex Research, Keyrus Life Science and the Faculty of Medicine and Health Sciences of the Université de Sherbrooke (FMSS) are joining forces to discover and develop innovative solutions against the SARS-CoV-2 virus.
Read More